Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

152.01
+0.25000.16%
Post-market: 152.010.00000.00%18:29 EDT
Volume:1.41M
Turnover:214.45M
Market Cap:290.04B
PE:21.77
High:152.55
Open:151.56
Low:151.24
Close:151.76
52wk High:170.46
52wk Low:111.06
Shares:1.91B
Float Shares:1.82B
Volume Ratio:1.35
T/O Rate:0.08%
Dividend:4.67
Dividend Rate:3.07%
EPS(TTM):6.98
EPS(LYR):7.15
ROE:34.93%
ROA:10.54%
PB:7.53
PE(LYR):21.26

Loading ...

China Commerce Ministry Says Companies Include Eli Lilly, Sanofi, Novartis, Merck - Statement

THOMSON REUTERS
·
May 22

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

MT Newswires Live
·
May 18

Novartis Says Prostate Cancer Treatment Lowers Progression Risk By 58%

MT Newswires Live
·
May 18

Novartis announces new data from PSMAddition

TIPRANKS
·
May 18

Dyne Can Unlock Value in Two Drug Prospects, RBC Says

MT Newswires Live
·
May 13

Novartis breaks ground on radioligand therapy manufacturing site in Texas

TIPRANKS
·
May 08

Novartis Starts Construction on Texas Cancer Therapy Manufacturing Facility

MT Newswires Live
·
May 08

Global Pharmaceutical Giants Report Robust Earnings, Increasing Investments in China

Deep News
·
May 07

Novartis Gains Canada Nod for Fabhalta in Rare Kidney Disease

MT Newswires Live
·
May 02

Novartis to Build Drug Ingredient Manufacturing Site in North Carolina

Dow Jones
·
Apr 30

Novartis AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 28

Novartis Shares Decline Following Disappointing Quarterly Results

Deep News
·
Apr 28

US Equity Futures Mostly Lower Pre-Bell Amid Continued Middle East Standoff, AI Spending Concerns

MT Newswires Live
·
Apr 28

Sector Update: Health Care

MT Newswires Live
·
Apr 28

Novartis reports Q1 core EPS $1.99 vs. $2.28 last year

TIPRANKS
·
Apr 28

Novartis Chief Predicts Trump's Drug Pricing Policy to Unfold Over Next Year and a Half

Deep News
·
Apr 28

European Pharma Stocks Slip After Novartis Books Sales, Profit Drop -- Market Talk

Dow Jones
·
Apr 28

Novartis Misses Quarterly Profit Estimates on Steep Generic Erosion

Reuters
·
Apr 28

Novartis Reaffirms FY2026 Outlook; Net Sales to Grow Low Single-Digit, Core Operating Income to Decline Low Single-Digit

Benzinga
·
Apr 28

Novartis Q1 Adj. EPS $1.99 Misses $2.13 Estimate, Sales $13.113B Miss $13.648B Estimate

Benzinga
·
Apr 28